|
Real-time
Euronext Paris
17:37:24 27/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.4490 EUR | -4.47% |
|
-19.82% | -61.88% |
| 10-22 | NFL Biosciences SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 10-22 | NFL Biosciences Gets Regulatory Approvals to Begin Phase 2 Nicotine Cessation Trial for NFL-102 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.47% | -19.82% | -38.32% | -46.48% | -61.88% | -60.20% | -55.10% | -88.66% | - | 6.66M | |
| +0.88% | -0.34% | -10.10% | +16.80% | +61.08% | +40.64% | +73.05% | +5.19% | - | 65.28B | |
| -0.13% | -0.18% | -7.79% | -1.39% | +8.65% | +9.60% | +77.16% | +223.96% | +5,423.40% | 54.57B | |
| -0.87% | +0.67% | +7.70% | +12.48% | +17.00% | +8.75% | +100.00% | -16.66% | +255.88% | 53.59B | |
| +3.47% | +2.93% | +1.75% | +29.31% | +22.31% | +26.80% | +53.22% | +8.42% | +282.39% | 45.03B | |
| -4.04% | -6.72% | -2.27% | +10.05% | +18.06% | +13.71% | +110.42% | -2.34% | +993.16% | 42.17B | |
| -0.05% | -7.49% | -9.87% | -3.32% | +128.29% | +213.56% | +877.08% | +559.06% | - | 39.42B | |
| -2.26% | -4.14% | +7.10% | +6.98% | +10.22% | +15.38% | +45.53% | +3.86% | +156.29% | 32.71B | |
| -2.70% | -10.77% | -16.37% | +15.52% | +42.05% | +19.80% | -6.47% | -61.99% | - | 24.01B | |
| +0.51% | +13.87% | +28.71% | +55.29% | +46.18% | +58.45% | +47.63% | +2.03% | +159.46% | 26.5B | |
| -1.03% | -6.25% | -13.74% | -6.17% | -10.22% | -19.41% | -6.28% | -69.34% | - | 21.82B | |
| +0.35% | -2.38% | -20.63% | -10.82% | -46.34% | -43.06% | +291.10% | +253.77% | +578.74% | 20.38B | |
| +0.28% | +8.60% | +9.74% | +14.69% | +20.35% | +13.32% | +170.07% | +220.96% | +2,251.91% | 18.93B | |
| +0.40% | +12.42% | +20.38% | +58.10% | +77.77% | +81.60% | +105.47% | -17.54% | +363.68% | 17.06B | |
| -0.60% | +8.20% | +8.59% | +27.73% | +36.99% | +38.81% | +84.70% | -16.52% | +107.58% | 16.69B | |
| +0.45% | +0.56% | +10.93% | +16.02% | +47.73% | +61.92% | +220.54% | +203.99% | +492.95% | 16.13B | |
| -0.31% | +4.46% | +6.40% | -3.41% | - | - | - | - | - | 16.1B | |
| -1.28% | -1.28% | +0.43% | +2.20% | +173.78% | +155.82% | +363.62% | +1,373.64% | +757.63% | 14.75B | |
| +1.28% | +6.17% | +5.33% | +9.57% | +1.49% | +1.59% | -21.41% | -34.36% | +129.78% | 14.18B | |
| -5.62% | -3.16% | -0.44% | -11.74% | +15.55% | +5.49% | +488.95% | - | - | 14.63B | |
| Average | -0.81% | +2.72% | -0.62% | +9.57% | +32.06% | +33.82% | +158.91% | +141.53% | +919.45% | 27.7B | |
| Weighted average by Cap. | -0.45% | +3.09% | -0.30% | +12.54% | +36.26% | +38.61% | +160.93% | +120.42% | +1,226.14% |
- Stock Market
- Stocks
- ALNFL Stock
- Sector NFL Biosciences
Select your edition
All financial news and data tailored to specific country editions
